Skip to main content

Doribax FDA Approval History

FDA Approved: Yes (Discontinued) (First approved October 12, 2007)
Brand name: Doribax
Generic name: doripenem
Dosage form: Injection
Company: Shionogi Inc.
Treatment for: Intraabdominal Infection, Urinary Tract Infection

Marketing Status: Discontinued

Doribax (doripenem) is a penem antibacterial indicated for the treatment of complicated intra-abdominal and complicated urinary tract infections, including pyelonephritis.

Development timeline for Doribax

Oct 15, 2007Approval FDA Approves Doribax for the Treatment of ComplicatedIntra-Abdominal and Complicated Urinary Tract Infections
Jun  6, 2007New Drug Application Submitted for Investigational AntibioticDoripenem
Dec 15, 2006New Drug Application Submitted for Investigational Antibiotic Doripenem

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.